Healthcare in the News

A Fish a Day Keeps Heart Woes at Bay

American Heart Association revises its guidelines for omega-3 fatty acids, which are plentiful in fish

< November 19, 2002 > The American Heart Association is boosting its recommendations about omega-3 fatty acids, telling people with known heart disease that getting enough of them, either in the diet or by taking supplements, can be life-saving.

People with documented heart disease are best off if they include in their diets 1 gram a day of two omega-3 fatty acids, eicosapentaenoic and docosehexaenoic acids, which are plentiful in such fish as mackerel, lake trout, herring, sardines, albacore, tuna, and salmon, say new guidelines just published in the American Heart Association's journal Circulation.

A third, less-potent kind, alpha-linoleic acid, found in such plants as soybeans, canola, walnuts, and flaxseed, is also recommended.

The American Heart Association's last guidelines, published in 2000, recommended at least two servings of oily fish each week both for healthy people and those with known heart disease.

The recommendation for people without heart disease remains unchanged.

But studies showing that omega-3 fatty acid consumption reduces cardiac deaths led to the change for people with known heart disease, says William S. Harris, professor of medicine at the University of Missouri, and a member of the committee that wrote the revised guidelines.

"New trials have been reported that finally broke the camel's back," Harris says. "The last report showed that giving 0.85 grams of omega-3 fatty acids to people who survived heart attacks caused a 20 percent reduction in overall mortality over three-and-a-half years. One of the big contributors to that reduction was a 45 percent decrease in sudden cardiac deaths."

The best way to include the recommended intake of the fatty acids for those with known heart disease is by eating oily fish every day, Harris says. People who find such fish distasteful can turn to dietary supplements—but only after they consult with their physicians about the supplements they plan to take, he says.

"There's still a concern about the quality of product that's out there," Harris says. "There are no standard measures of omega-3 fatty acid content in supplements. Many of them are very good, but we can't make recommendations about specific products, so we're dumping the issue to the physicians."

Some people—those with elevated blood triglyceride levels, for instance—may need 2 to 4 grams a day of the omega-3 fatty acids, the guidelines say. But anyone taking at least 3 grams daily should do so only under a physicians' supervision, because high intakes might cause excessive bleeding.

The two servings a week of oily fish recommended for people without heart disease works out to "in the neighborhood of 300 to 400 milligrams a day," Harris says. The epidemiological evidence for that recommendation is not as strong as might be desired, he adds, but there is a feeling that it will do most people good.

There are exceptions to the two-serving recommendation. Children, pregnant women, and nursing mothers are advised to avoid fish that the US Food and Drug Administration (FDA) has listed as posing potential mercury hazards: king mackerel, tilefish, swordfish, and shark.

Fish oil researchers like Harris—he has been researching this subject for more than 20 years—are still studying the mechanisms by which omega-3 fatty acids reduce coronary risk. But studies have shown they reduce the likelihood of blood clots, lower blood pressure, decrease blood levels of harmful fats, and interfere with the growth of artery-blocking plaque deposits.

Always consult your physician for more information.


Online Resources

(Our Organization is not responsible for the content of Internet sites.)

American Collegy of Cardiology

American Heart Association

National Heart, Lung, and Blood Institute

For more information on heart disease, please visit the Cardiovascular Diseases information module on this Web site.


In Other Heart Care News:

Treatment Guidelines Call for ACE Inhibitors

New recommendations suggest increased use of blood pressure drugs for stable angina

Increased use of ACE inhibitor drugs could reduce heart attacks and strokes and save the lives of people with chronic chest pain caused by stable angina.
That finding is behind new treatment guidelines from the American College of Cardiology and the American Heart Association.

ACE (angiotensin-converting enzyme) inhibitors are a class of drugs used to treat high blood pressure.

Stable angina refers to chest discomfort that does not change for weeks or months and usually occurs during exertion or when a person is emotionally upset.

The new guidelines recommend that ACE inhibitors should be routinely offered to people who have had a heart attack or those with coronary artery disease that has been documented with angiography, if those people also have diabetes or diminished function in their heart's left ventricle.

Dr. Robert O. Bonow, president of the American Heart Association, says the new ACE inhibitor guidelines should significantly reduce the rates of heart attack, stroke, and death.

He says the ACE inhibitors benefit these people by lowering blood pressure, dilating blood vessels, slowing plaque growth in arteries, and preventing blood clots.

The new guidelines are based on findings from the Heart Outcome Prevention Evaluation (HOPE) trial, which compared the ACE inhibitor ramipril against a placebo in more than 9,000 people with vascular disease.

Always consult your physician for more information.